NMRA-323511
NMRA-323511-104
Phase 1 small_molecule completed
Quick answer
NMRA-323511 for Alzheimer's Disease is a Phase 1 program (small_molecule) at Neumora Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Neumora Therapeutics
- Indication
- Alzheimer's Disease
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed